Summary
76 / 100 · Bulios Score
What speaks for it
- Earnings per share grew by 57% a year over the last 3 years.
- The share price is below the Bulios Fair Price.
- Analysts expect revenue to grow by 93% this fiscal year.
What to watch
None of the indicators we track raises a caution right now.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 13.0 USD for 1 USD of yearly profit. Over the last five years it was 15.1 USD on average.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 26% a year over 5 years. Over the last 3 years it grew by 30% a year. For the next fiscal year analysts expect revenue to grow by 93%. Earnings per share grew by 57% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 USD of revenue goes
- Cost of sales 66 USD
- Sales and administration 20 USD
- Taxes and other 3.2 USD
- Net profit 11 USD
Net profit, industry median (Insurance - Property & Casualty) 11 USD
Out of every 100 USD of revenue, 11 USD is left as net profit.
Profitability in detailIs it financially healthy?
Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 8
- Hold 4
- Sell 0
Today's price within the analysts' price targets
The average target of $66.33 is 8.3% above today's price. 67% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.